GB2260702B - Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X - Google Patents

Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X

Info

Publication number: GB2260702B
Authority: GB; United Kingdom
Prior art keywords: haemophilia; factor; treatment; subcutaneous injection; improvements relating
Prior art date: 1991-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

GB9222012A

Other versions

GB2260702A (en

GB9222012D0 (en

Inventor

George Gow Brownlee

Ann Justine Gerrard

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BTG International Ltd

Original Assignee

British Technology Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-24

Filing date

1992-10-20

Publication date

1995-09-20

1992-10-20 Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd

1992-12-02 Publication of GB9222012D0 publication Critical patent/GB9222012D0/en

1993-04-28 Publication of GB2260702A publication Critical patent/GB2260702A/en

1995-09-20 Application granted granted Critical

1995-09-20 Publication of GB2260702B publication Critical patent/GB2260702B/en

2012-10-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Treatments Of Macromolecular Shaped Articles (AREA)

GB9222012A 1991-10-24 1992-10-20 Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X Expired - Fee Related GB2260702B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919122609A GB9122609D0 (en)	1991-10-24	1991-10-24	Improvements relating to the treatment of haemophilia

Publications (3)

Publication Number	Publication Date
GB9222012D0 GB9222012D0 (en)	1992-12-02
GB2260702A GB2260702A (en)	1993-04-28
GB2260702B true GB2260702B (en)	1995-09-20

Family

ID=10703480

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB919122609A Pending GB9122609D0 (en)	1991-10-24	1991-10-24	Improvements relating to the treatment of haemophilia
GB9222012A Expired - Fee Related GB2260702B (en)	1991-10-24	1992-10-20	Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
GB919122609A Pending GB9122609D0 (en)	1991-10-24	1991-10-24	Improvements relating to the treatment of haemophilia

Country Status (5)

Country	Link
EP (1)	EP0609293A1 (en)
JP (1)	JPH07502989A (en)
AU (1)	AU2772092A (en)
GB (2)	GB9122609D0 (en)
WO (1)	WO1993007890A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE504074C2 (en) †	1993-07-05	1996-11-04	Pharmacia Ab	Protein preparation for subcutaneous, intramuscular or intradermal administration
IL113010A (en) *	1994-03-31	1999-10-28	Pharmacia & Upjohn Ab	Pharmaceutical formulation comprising factor viii with an activity of at least 500iu/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US7786070B2 (en)	1997-09-10	2010-08-31	Novo Nordisk Healthcare A/G	Subcutaneous administration of coagulation factor VII
JP5090605B2 (en)	2000-05-03	2012-12-05	ノボノルディスクヘルスケアアクチェンゲゼルシャフト	Subcutaneous administration of coagulation factor VII
WO2011020866A2 (en) *	2009-08-20	2011-02-24	Csl Behring Gmbh	Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991010439A1 (en) *	1990-01-19	1991-07-25	Octapharma Ag	Stable injectible solutions for factor viii and factor ix

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0430930B1 (en) *	1985-03-15	1993-09-01	Btg International Limited	Factor ix protein

1991
- 1991-10-24 GB GB919122609A patent/GB9122609D0/en active Pending
1992
- 1992-10-20 GB GB9222012A patent/GB2260702B/en not_active Expired - Fee Related
- 1992-10-20 AU AU27720/92A patent/AU2772092A/en not_active Abandoned
- 1992-10-20 EP EP92921475A patent/EP0609293A1/en not_active Withdrawn
- 1992-10-20 WO PCT/GB1992/001926 patent/WO1993007890A1/en not_active Application Discontinuation
- 1992-10-20 JP JP5507561A patent/JPH07502989A/en active Pending

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991010439A1 (en) *	1990-01-19	1991-07-25	Octapharma Ag	Stable injectible solutions for factor viii and factor ix

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Br.J.Haematol. 81(4) pages 610-3 August 1992 *
Dictionnaire Vidal (1990) page 653 "Facteur IX humain haute purete" *
Martindale, The Extra Pharmacopoeia, 29th Edition (1989) page 817 entry 1227-a *

Also Published As

Publication number	Publication date
GB2260702A (en)	1993-04-28
WO1993007890A1 (en)	1993-04-29
EP0609293A1 (en)	1994-08-10
AU2772092A (en)	1993-05-21
JPH07502989A (en)	1995-03-30
GB9122609D0 (en)	1991-12-04
GB9222012D0 (en)	1992-12-02

Publication	Publication Date	Title
DE69030591D1 (en)	1997-05-28	Subcutaneous injection
GB9016789D0 (en)	1990-09-12	Medicament administering devices
IL102941A0 (en)	1993-01-31	Injection syringe
EP0356810A3 (en)	1990-11-14	Self-sheathing hypodermic needle
HUT59017A (en)	1992-04-28	Injection syringe
IL101360A0 (en)	1992-11-15	Injection syringe
DE69331626D1 (en)	2002-04-04	Multi-purpose infusion cannula
GB9111600D0 (en)	1991-07-24	Improvements relating to injection devices
EP0544653A3 (en)	1993-08-18	Injection site
GB9020749D0 (en)	1990-11-07	Improved single-use syringe
GB8911487D0 (en)	1989-07-05	Therapeutic stockings
HU9302192D0 (en)	1993-11-29	Injection needle
ZA899066B (en)	1991-07-31	Fabric treatment composition
GB2260702B (en)	1995-09-20	Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
GB8725029D0 (en)	1987-12-02	Inclined-edge controlled fuel injection pump
GB2248021B (en)	1994-08-17	Vein needle set
GB9101525D0 (en)	1991-03-06	Improvements in or relating to the protection of needle points
NO960545D0 (en)	1996-02-12	Treatment of adverse effects associated with the administration of extracellular hemoglobin
EP0505579A4 (en)	1993-04-28	Injector supplied with medicine
GB9000761D0 (en)	1990-03-14	Syringe needle with safety feature
ZA899065B (en)	1991-07-31	Fabric treatment composition
GB2241893B (en)	1994-01-05	Hypodermic syringe
IE860956L (en)	1986-10-15	Administering insulin
PL283596A1 (en)	1991-08-12	Disposable injection needle
ZA907531B (en)	1991-07-31	Injection syringe

Legal Events

Date	Code	Title	Description
1997-06-11	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 19961020